NY-ZOOP
Led by a robust team of Web3 developers and former OnlyFans executives, Zoop is set to launch their digital collectable trading platform powered by Polygon , the decentralized Ethereum scaling ecosystem. Zoop’s platform allows users to buy, sell, collect and trade 3D digital playing cards of their favorite celebrities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220526005159/en/
On Zoop, fans can acquire officially licensed, limited edition digital cards, and are able to sell and trade them in a secondary market.
“Zoop is the trusted home for authentic celebrity card drops, enabling all fans, regardless of their technical expertise, to participate in the web3.0 space. We hold users' hands as they compete in acquiring digital collectables in the auction process, show off their holdings to friends and ‘collect-to-connect’ with their favorite celebrities of today and tomorrow. Zoop provides access to communities based on the cards users own, and rewards points to users for their interactions with each other and within these communities. We are excited to be launching Summer 2022,” says RJ Phillips, Founder and co-CEO of Zoop. “It’s a win for the celebrities, creates excitement for the fans and a new way for brands to connect with their customers,” he said.
Zoop is capitalizing on the booming blockchain gamification market, which grew to a $40 billion industry in 2021. And, by 2026, the industry is predicted to grow to $147 billion . By opening up the platform and combining it with today’s influencer-driven creator economy, Zoop’s app allows fans to collect 3D digital trading cards from their favorite influencers and celebrities, fostering a closer connection between fan and influencer. Fans can buy, sell, and trade cards, as well as compete in competitions and challenges to gain points, unlocking special rewards including access to like- minded communities. Zoop’s inclusive ecosystem is creating value for digital trading cards by enabling a fully transparent leaderboard.
The Zoop team will be led by co-CEOs Tim Stokely, tech Entrepreneur and founder of OnlyFans, and RJ Phillips. Tim, who will be joining the team in time for the launch this summer, brings extensive knowledge of the creator economy and a proven track record in building a true tech unicorn while RJ’s expertise in growth and scaling make for the perfect leadership team. Together, Tim and RJ plan to leverage their past career successes and knowledge of the creator economy to ultimately scale Zoop into a global digital trading card ecosystem that drives value for both creators and fans alike.
As a precursor to its initial launch, Zoop is offering a limited number of pre-launch Priority Passes (PP), which reward the earlier adopters with a host of perks, both in-app and real-life, in addition to exclusive airdrops only for PP holders. The first batch of these Priority Passes are available now at mint.zoopcards.com .
Zoop will be building its digital marketplace on the globally recognized Polygon blockchain network. Like Zoop, Polygon believes in Web3 for all, making them an ideal partner and blockchain of choice for the Zoop platform. Their low transaction costs and high security standard make card trading on Zoop safe and accessible for all. Additionally, Polygon’s sustainability commitment to make all their NFTs carbon-negative by the end of 2022 was another important factor for Zoop.
“We're delighted to be working with the Zoop team as they build out their platform on Polygon. Zoop aligns with our mission to bring Web3 technologies to a much broader demographic, and allowing fans to connect to their favorite celebrities via Polygon is another step towards this goal," said Michael Blank, COO of Polygon Studios, who has been providing Zoop with a suite of services such as technical support, Web3 game design and distribution, asset expansion and more.
Zoop's announcement comes just weeks after Instagram began minting their non-fungible tokens (NFTs) on Polygon's carbon-neutral network as well.
About Zoop
Zoop is building an entire ecosystem based on officially licensed celebrity digital trading cards. Fans are easily able to buy, sell, trade and collect the celebrities and influencers they idolize and admire through cutting edge blockchain technology. On Zoop, fans can build out their card collections and earn fan rewards with exclusive celebrity experiences whilst forging communities of like-minded collectors. Zoop cards garner authenticity through official partnerships with an unrivaled roster of celebrities and brands onboard. To learn more visit www.zoopcards.com .
Website | Twitter | Telegram | LinkedIn | Discord | Instagram | Facebook | Mint Page | Support Twitter | Medium | Tim’s Instagram | RJ’s Instagram
About Polygon
Polygon is the leading platform for Ethereum scaling and infrastructure development. Its growing suite of products offers developers easy access to all major scaling and infrastructure solutions: L2 solutions (ZK Rollups and Optimistic Rollups), sidechains, hybrid solutions, stand-alone and enterprise chains, data availability solutions, and more. Polygon’s scaling solutions have seen widespread adoption with 19,000+ applications hosted, 3.4B+ total transactions processed, ~135M+ unique user addresses, and $5B+ in assets secured.
If you're an Ethereum Developer, you're already a Polygon developer! Leverage Polygon’s fast and secure txns for your dApp, get started here .
Website | Twitter | Ecosystem Twitter | Developer Twitter | Studios Twitter | Telegram | LinkedIn | Reddit | Discord | Instagram | Facebook
About Polygon Studios
Polygon Studios aims to be the home of the most popular blockchain projects in the world. The Polygon Studios team is focused on supporting developers building decentralized apps on Polygon by providing Web2 and Web3 teams with a suite of services such as developer support, partnership, strategy, go-to-market, and technical integrations. Polygon Studios supports projects from OpenSea to Prada, from Adidas to Draft Kings and Decentral Games to Ubisoft.
Twitter | Facebook | Instagram | Telegram | Tiktok | LinkedIn
DISCLAIMER: Except where otherwise noted, the information contained in this release is as of May 26, 2022. We assume no obligation to update any forward-looking statements contained in this release as a result of new information or future events or developments. We cannot guarantee that any forward-looking statement will be realized. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Readers are cautioned not to put undue reliance on forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005159/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Lone Star Announces Sale of SPX FLOW to ITT Inc.5.12.2025 13:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced the signing by an affiliate of Lone Star Fund XI, LP of a definitive agreement to sell SPX FLOW, Inc. (“SPX FLOW”), a leading provider of highly engineered equipment and process technologies for attractive end markets including industrial, health and nutrition, to ITT Inc. (NYSE: ITT) for $4.775 billion in cash and shares of common stock. Based in Charlotte, N.C., SPX FLOW focuses on process technologies delivering mixing, blending, fluid handling, separation, thermal heat transfer and other solutions integral to industrial, health and nutrition markets. The company has operations in more than 25 countries and sales in more than 140 countries. In partnership with Lone Star, SPX FLOW has focused on improving its sales execution and operating platform, while ensuring high quality and innovative product development. The management team has improved the company’s commercial organization and executed growth initiatives to build its presence in e
AmTrust Financial Services and Blackstone Credit & Insurance Close Strategic Transaction and Launch Newly Formed Multinational MGACompany Named ANV Group Holdings Ltd.5.12.2025 13:00:00 CET | Press release
Strategic Transaction Unlocks Value for AmTrust and Positions ANV Group Holdings for Accelerated GrowthFormer AmTrust President Adam Karkowsky Leading ANV Group Holdings as Chairman and CEO AmTrust Financial Services, Inc. (“AmTrust” or the “Company”), a global specialty property casualty insurer, and Blackstone Credit & Insurance (“BXCI”), today announced the closing of a strategic transaction under which AmTrust and funds managed by BXCI have partnered to spin-off certain of AmTrust’s Managing General Agencies (“MGAs”) and fee-based businesses in the U.S., United Kingdom, and Continental Europe, into ANV Group Holdings Ltd. (“ANV”), a newly formed independent company, following receipt of regulatory approvals. AmTrust and ANV have entered into a ten-year capacity agreement through which AmTrust will remain the underwriter for the existing books of business offered through the MGAs. As previously announced on September 15, 2025, the agreement includes seven AmTrust subsidiaries: ANV S
Galderma Opens up New Chapter for Sculptra® with MDR Certification and New Expanded Indication for Body5.12.2025 07:00:00 CET | Press release
Sculptra®, the first proven regenerative biostimulator, has received European Union (EU) Medical Device Regulation (MDR) certification, expanding its current clinical application for the face to include gluteal area, posterior thighs, décolletage, and upper arms1 Studies investigating the efficacy of Sculptra on areas beyond the face show patients experienced progressive improvements in skin quality (including the improvement in cellulite appearance), firmness, lift, projection, and contour Sculptra’s versatility and new indication allow practitioners to shift patient treatment goals beyond rejuvenation toward enhancement, meeting evolving patient needs The certification validates Sculptra’s safety performance, efficacy, and quality, reinforcing Galderma’s commitment to innovation and meeting evolving patient needs Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the certification of Sculptra for body indications in the European Union (EU) following its
Northern Escape Heli-Skiing Takes the Title of “World’s Best Heli-Ski-Operator” for the 4th Year Running5.12.2025 02:40:00 CET | Press release
4x World’s Best Heli-Skiing Operation near Terrace, BC Northern Escape Heli-Skiing (NEH) has been named World’s Best Heli-Ski Operator 2025 by the World Ski Awards, marking its fourth straight victory following years 2022, 2023 and 2024. This recognition places NEH amongst an elite group of ski tourism operators consistently voted best in the world by industry leaders and enthusiasts alike. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204074550/en/ A four-year run built on reliability NEH operates in British Columbia’s Skeena Mountains, where deep northern snow and vast terrain come together with small-group heli-skiing and heli snowboarding. When helicopters can’t safely fly, NEH has cat skiing readily available as a backup — an exceedingly rare offering in this industry. The operation spans over 833,571 wild acres of alpine bowls, glaciers and old-growth tree skiing. The NEH experience Guests choose from three lodge f
IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance5.12.2025 01:00:00 CET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollment in Q1 2026, initially evaluating patients with solid tumors known to express B7H3 and PTK7, including lung, colorectal, head and neck, and ovarian/gynecological cancers. IDE034 is a bispecific B7H3/PTK7 TOP1 ADC, independently developed by Biocytogen and licensed to IDEAYA in July 2024. The IND clearance marks an important milestone for this licensed program, supporting subsequent clinical development of IDE034, while highlighting Biocytogen’s technical capabilities in bispecific ADC discovery and development. Dr. Yue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom